Control of ovulation-induced hemoperitoneum by oral contraceptives in a patient with congenital hypoprothrombinemia and in another with congenital factor V deficiency

Acta Haematologica

Volumn 119, Issue 4, 2008, Pages 236-240

  Girolami, A ^a,b   Lombardi, A M ^a   Candeo, N ^a   Scarparo, P ^a   Paternoster, A ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Department of Medical and Surgical Sciences   (Italy)

Author keywords

Factor V deficiency; Hemoperitoneum; Hemorrhagic corpus luteum; Oral contraceptives; Ovulation; Prothrombin deficiency

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE; FRESH FROZEN PLASMA; ORAL CONTRACEPTIVE AGENT; PROTHROMBIN COMPLEX;

ADULT; ARTICLE; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD TRANSFUSION; CASE REPORT; FEMALE; FOLLOW UP; HEMOPERITONEUM; HUMAN; HYPOPROTHROMBINEMIA; LAPAROSCOPY; MENARCHE; MENSTRUAL CYCLE; METRORRHAGIA; ORAL CONTRACEPTION; OVARIECTOMY; OVULATION; PLASMA TRANSFUSION; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; BLOOD COMPONENT TRANSFUSION; CONTRACEPTIVES, ORAL; FACTOR V DEFICIENCY; FEMALE; HEMOPERITONEUM; HUMANS; HYPOPROTHROMBINEMIAS; LAPAROSCOPY; MENORRHAGIA; OVULATION INHIBITION; RECURRENCE;

EID: 47949128765     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000141782     Document Type: Article

References (27)

1. Hallatt JG, Steele CH Jr, Snyder M: Ruptured corpus luteum with hemoperitoneum: a study of 173 surgical cases. Am J Obstet Gynecol 1984;149:5-9.
2. Bogers JW, Huikeshoven FJ, Lotgering FK: Complications of anticoagulant therapy in ovulatory women. Lancet 1991;337:618-619.
3. Crétel E, Cacoub P, Gompel A, Durand JM, Piette JC: Hémopéritoines d'origine ovarienne compliquant les traitements par antivitamine K. Rev Méd Interne 2000;21:428-434.
4. Jamal A, Mesdaghinia S: Ruptured corpus luteum cysts and anticoagulant therapy. Int J Gynaecol Obstet 2002;76:319-320.
5. Nazarian LN, Lev-Toaff AS, Spettell CM, Wechsler RJ: CT assessment of abdominal hemorrhage in coagulopathic patients: impact on clinical management. Abdom Imaging 1999;24:246-249.
6. Gomez A, Lucia JF, Perella M, Aguilar C: Haemoperitoneum caused by haemorrhagic corpus luteum in a patient with type 3 von Willebrand's disease. Haemophilia 1998;4:60-62.
7. Ghosh K, Mohanty D, Pathare AV, Jijina F: Recurrent haemoperitoneum in a female patient with type III von Willebrand's disease responded to administration of oral contraceptive. Haemophilia 1998;4:767-768.
8. Jarvis RR, Olsen ME: Type I von Willebrand's disease presenting as recurrent corpus hemorrhagicum. Obstet Gynecol 2002;99:887-888.
9. Kouides PA, Phatak PD, Burkart P, Braggins C, Cox C, Bernstein Z, Belling L, Holmberg P, MacLaughlin W, Howard F: Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia 2000;6:643-648.
10. Bottini E, Pareti FI, Mari D, Mannucci PM, Muggiasca ML, Conti M: Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports. Haematologica 1991;76:431-433.
11. Castaman G, Ruggeri M, Rodeghiero F: Congenital afibrinogenemia: successful prevention of recurrent hemoperitoneum during ovulation by oral contraceptive. Am J Hematol 1995;49:363-364.
12. Schneider D, Bukovsky I, Kaufman S, Sadovsky G, Caspi E: Severe ovarian hemorrhage in congenital afibrinogenemia. Acta Obstet Gynecol Scand 1981;60:431.
13. RoquéH, Stephenson C, Lee MJ, Funai EF, Popiolek D, Kim E, Hart D: Pregnancy-related thrombosis in a woman with congenital afibrinogenemia: a report of two successful pregnancies. Am J Hematol 2004;76:267-270.
14. Lak M, Peyvandi F, Ali Sharifian A, Karimi K, Mannucci PM: Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost 2003;1:1852-1853.
15. Dafopoulos K, Galazios G, Georgadakis G, Boulbou M, Koutsoyiannis D, Plakopoulos A, Anastasiadis P: Two episodes of hemoperitoneum from luteal cysts rupture in a patient with congenital factor X deficiency. Gynecol Obstet Invest 2003;55:114-115.
16. Payne JH, Maclean RM, Hampton KK, Baxter AJ, Makris M: Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill. Haemophilia 2007;13:93-97.
17. Gupta N, Dadhwal V, Deka D, Jain SK, Mittal S: Corpus luteum hemorrhage: rare complication of congenital and acquired coagulation abnormalities. J Obstet Gynaecol Res 2007;33:376-380.
18. Girolami A: L'ipoprotrombinemia congenita. Prog Med 1975;31:107-122.
19. Girolami A, Scarpa R, Brunetti A, Lazzarin M: Congenital factor V deficiency in a 15-months old child. Coagulation 1969;2:343-346.
20. Greer IA, Lowe GD, Walker JJ, Forbes CD: Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991;98:909-918.
21. James AH: More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia 2005;11:295-307.
22. Girolami A, Scandellari R, Lombardi AM, Girolami B, Bortoletto E, Zanon E: Pregnancy and oral contraceptives in factor V deficiency: a study of 22 patients (five homozygotes and 17 heterozygotes) and review of the literature. Haemophilia 2005;11:26-30.
23. Girolami A, Randi ML, Ruzzon E, Lombardi AM, Girolami B, Fabris F: Pregnancy and oral contraceptives in congenital bleeding disorders of the vitamin K-dependent coagulation factors. Acta Haematol 2006;115:58-63.
24. Knight RD, Barr CF, Alving BM: Replacement therapy for congenital factor X deficiency. Transfusion 1985;25:78-80.
25. Hann LE, Hall DA, Black EB, Ferrucci JT Jr: Mittelschmerz. Sonographic demonstration. JAMA 1979;241:2731-2732.
26. Vandenbroucke JP, Rosing J, Bloemenkamp KW, Middeldorp S, Helmerhorst FM, Bouma BN, Rosendaal FR: Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001;344:1527-1535.
27. Girolami A, Spiezia L, Girolami B, Zocca N, Luzzatto G: Effect of age on oral contraceptive-induced venous thrombosis. Clin Appl Thromb Hemost 2004;10:259-263.